Joe Biden's battle with stage 4 metastatic prostate cancer has raised new questions about when his illness began, after a ...

Researchers at Texas A&M Health have identified a molecular mechanism that increases cholesterol levels inside prostate ...

Low testosterone levels may increase the risk of higher-grade “extreme” progression of prostate cancer among men enrolled in active surveillance (AS), acc ...

Sessions of Proton Therapy to Control Early-Stage Prostate Cancer HONG KONG, March 20, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) today announced the results of Asia's first clinical study on ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), an oral poly ADP-ribose ...

This may not apply in your husband’s case, but it’s worth having the conversation. The two meds Goldstein prescribes for men are flibanserin (Addyi), an oral tablet taken d ...

A groundbreaking randomized clinical trial led by Chair of Radiation Oncology Daniel Spratt at University Hospitals Seidman ...

Prostate Cancer Foundation of Australia (PCFA) is proud to be named the official charity partner for this year's Australian Sheep and Wool Show in ...

ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that multiple abstracts ...

A foundational guide for stage 2 prostate cancer clarifies staging implications, localized-disease management, and trade-offs among surgery, radiation, and quality-of-life outcomes to support informed ...

The Lehigh Valley Auto Show showcases innovation, creativity, and automotive excellence, drawing car enthusiasts from across the region. This year, it will also put men’s health in the spotlight with ...

Healthcare provider, LivingCare Group has been selected as the proposed imaging partner for the IMProVE clinical trial, a prostate cancer early-detection programme funded by Yorkshire Cancer Research.